Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate The Chemours Company before investing.

In this article, we go over a few key elements for understanding The Chemours Company’s stock price such as:

• The Chemours Company’s current stock price and volume
• Why The Chemours Company’s stock price changed recently
• Upgrades and downgrades for CC from analysts
• CC’s stock price momentum as measured by its relative strength

About The Chemours Company (CC)

Before we jump into The Chemours Company’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. The company sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Want to learn more about The Chemours Company’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about The Chemours Company.

The Chemours Company’s Stock Price as of Market Close

As of November 28, 2025, 1:04 PM, CST, The Chemours Company’s stock price was $12.790.

The Chemours Company is up 2.57% from its previous closing price of $12.470.

During the last market session, The Chemours Company’s stock traded between $12.450 and $12.790. Currently, there are approximately 150.32 million shares outstanding for The Chemours Company.

The Chemours Company’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

The Chemours Company Stock Price History

The Chemours Company’s (CC) price is currently down 4.48% so far this month.

During the month of November, The Chemours Company’s stock price has reached a high of $13.340 and a low of $10.440.

Over the last year, The Chemours Company has hit prices as high as $22.265 and as low as $9.130. Year to date, The Chemours Company’s stock is down 24.32%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused The Chemours Company Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 26, 2025, there were 3 analysts who downgraded The Chemours Company’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate The Chemours Company’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on The Chemours Company’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

The Chemours Company’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about The Chemours Company (CC) by visiting AAII Stock Evaluator.

Relative Price Strength of The Chemours Company

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 26, 2025, The Chemours Company has a weighted four-quarter relative price strength of -14.10%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how The Chemours Company is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

The Chemours Company Stock Price: Bottom Line

As of November 28, 2025, The Chemours Company’s stock price is $12.790, which is up 2.57% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like The Chemours Company stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.